Literature DB >> 21030540

Composition and structure elucidation of human milk glycosaminoglycans.

Giovanni V Coppa1, Orazio Gabrielli, Dania Buzzega, Lucia Zampini, Tiziana Galeazzi, Francesca Maccari, Enrico Bertino, Nicola Volpi.   

Abstract

To date, there is no complete structural characterization of human milk glycosaminoglycans (GAGs) available nor do any data exist on their composition in bovine milk. Total GAGs were determined on extracts from human and bovine milk. Samples were subjected to digestion with specific enzymes, treated with nitrous acid, and analyzed by agarose-gel electrophoresis and high-performance liquid chromatography for their structural characterization. Quantitative analyses yielded ∼7 times more GAGs in human milk than in bovine milk. In particular, galactosaminoglycans, chondroitin sulfate (CS) and dermatan sulfate (DS), were found to differ considerably from one type of milk to the other. In fact, hardly any DS was observed in human milk, but a low-sulfated CS having a very low charge density of 0.36 was found. On the contrary, bovine milk galactosaminoglycans were demonstrated to be composed of ∼66% DS and 34% CS for a total charge density of 0.94. Structural analysis performed by heparinases showed a prevalence of fast-moving heparin over heparan sulfate, accounting for ∼30-40% of total GAGs in both milk samples and showing lower sulfation in human (2.03) compared with bovine (2.28). Hyaluronic acid was found in minor amounts. This study offers the first full characterization of the GAGs in human milk, providing useful data to gain a better understanding of their physiological role, as well as of their fundamental contribution to the health of the newborn.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030540     DOI: 10.1093/glycob/cwq164

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  22 in total

1.  Transforming growth factor-β2 is sequestered in preterm human milk by chondroitin sulfate proteoglycans.

Authors:  Kopperuncholan Namachivayam; Hayley P Coffing; Nehru Viji Sankaranarayanan; Yingzi Jin; Krishnan MohanKumar; Brandy L Frost; Cynthia L Blanco; Aloka L Patel; Paula P Meier; Steven A Garzon; Umesh R Desai; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-04       Impact factor: 4.052

2.  Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns.

Authors:  Francesca Maccari; Veronica Mantovani; Orazio Gabrielli; Antonio Carlucci; Lucia Zampini; Tiziana Galeazzi; Fabio Galeotti; Giovanni V Coppa; Nicola Volpi
Journal:  Glycoconj J       Date:  2016-02-13       Impact factor: 2.916

3.  Human milk hyaluronan enhances innate defense of the intestinal epithelium.

Authors:  David R Hill; Hyunjin K Rho; Sean P Kessler; Ripal Amin; Craig R Homer; Christine McDonald; Mary K Cowman; Carol A de la Motte
Journal:  J Biol Chem       Date:  2013-08-15       Impact factor: 5.157

4.  Specific-sized hyaluronan fragments promote expression of human β-defensin 2 in intestinal epithelium.

Authors:  David R Hill; Sean P Kessler; Hyunjin K Rho; Mary K Cowman; Carol A de la Motte
Journal:  J Biol Chem       Date:  2012-07-03       Impact factor: 5.157

5.  Determination of hyaluronan molecular mass distribution in human breast milk.

Authors:  Han Yuan; Ripal Amin; Xin Ye; Carol A de la Motte; Mary K Cowman
Journal:  Anal Biochem       Date:  2015-01-09       Impact factor: 3.365

Review 6.  Clinical applications of bioactive milk components.

Authors:  David R Hill; David S Newburg
Journal:  Nutr Rev       Date:  2015-07       Impact factor: 7.110

7.  Human milk glycosaminoglycans inhibit cytomegalovirus and respiratory syncytial virus infectivity by impairing cell binding.

Authors:  Rachele Francese; Manuela Donalisio; Massimo Rittà; Federica Capitani; Veronica Mantovani; Francesca Maccari; Paola Tonetto; Guido E Moro; Enrico Bertino; Nicola Volpi; David Lembo
Journal:  Pediatr Res       Date:  2022-05-05       Impact factor: 3.756

Review 8.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

9.  Human milk glycosaminoglycans inhibit in vitro the adhesion of Escherichia coli and Salmonella fyris to human intestinal cells.

Authors:  Giovanni V Coppa; Bruna Facinelli; Gloria Magi; Emanuela Marini; Lucia Zampini; Veronica Mantovani; Tiziana Galeazzi; Lucia Padella; Rita L Marchesiello; Lucia Santoro; Alessandra Coscia; Chiara Peila; Nicola Volpi; Orazio Gabrielli
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

10.  The Protective Influence of Chondroitin Sulfate, a Component of Human Milk, on Intestinal Bacterial Invasion and Translocation.

Authors:  Kathryn Y Burge; Lindsey Hannah; Jeffrey V Eckert; Aarthi Gunasekaran; Hala Chaaban
Journal:  J Hum Lact       Date:  2019-05-03       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.